Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

BFRIW BIOFRONTERA INC C/WTS 27/10/2026 (TO PUR COM)

Watchlist
0.2220.0000.00%
Close  01/31 16:00 ET
High
0.230
Open
0.230
Turnover
129.00
Low
0.222
Pre Close
0.222
Volume
573.00
Market Cap
0
P/E(TTM)
0.00
52wk High
4.410
Shares
0
P/E(Static)
0.00
52wk Low
0.160
Float Cap
0
Bid/Ask %
0.00%
Historical High
9.180
Shs Float
0
Volume Ratio
2.12
Historical Low
0.160
Dividend TTM
--
Div Yield TTM
--
P/B
0.00
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
3.65%
Avg Price
0.225
Lot Size
1
Float Cap
0
Bid/Ask %
0.00%
Historical High
9.180
Shs Float
0
Volume Ratio
2.12
Historical Low
0.160
Dividend TTM
--
P/B
0.00
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
3.65%
Avg Price
0.225
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company is focused on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.
CEO: Ms. Erica Monaco, C.P.A.
Market: NASDAQ
Listing Date: 10/29/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist